EPISODE · Mar 2, 2017 · 18 MIN
Response assessment criteria for immunotherapy drugs: The Lancet Oncology: March 2017
from Listen to The Lancet Oncology · host The Lancet
Lesley Seymour discusses the iRECIST guidelines for assessing tumour responses in immunotherapy trials.
Embed this episode
NOW PLAYING
Response assessment criteria for immunotherapy drugs: The Lancet Oncology: March 2017
0:00
18:17
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Listen to The Lancet Oncology?
This episode is 18 minutes long.
When was this Listen to The Lancet Oncology episode published?
This episode was published on March 2, 2017.
Can I download this Listen to The Lancet Oncology episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!